BIT
MCRB icon

BlackRock Institutional Trust’s Seres Therapeutics MCRB Stock Holding History

BlackRock Institutional Trust’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.82M Buy
24,358
+3,010
+14% +$656K ﹤0.01% 2741
2016
Q3 		$5.25M Buy
21,348
+7,403
+53% +$2.6M ﹤0.01% 2670
2016
Q2 		$8.1M Buy
13,945
+4,396
+46% +$2.58M ﹤0.01% 2416
2016
Q1 		$5.07M Sell
9,549
-51
-0.5% -$26.6K ﹤0.01% 2661
2015
Q4 		$6.74M Buy
9,600
+1,657
+21% +$1.09M ﹤0.01% 2564
2015
Q3 		$4.71M Buy
+7,943
New +$6.48M ﹤0.01% 2753

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock Institutional Trust's MCRB Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Seres Therapeutics (MCRB) stake by 14% in Q4 2016, buying an estimated $656K and bringing the position to 24,358 shares worth $4.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2741.

BlackRock Institutional Trust first reported a position in MCRB in Q3 2015 and has held it in 6 quarters since. The position peaked at $8.1M in Q2 2016. 89 funds tracked by Wall St. Rank hold MCRB as of Q4 2016.

  • BlackRock Institutional Trust held 24,358 shares of Seres Therapeutics worth $4.82M as of Q4 2016.
  • BlackRock Institutional Trust bought 3,010 Seres Therapeutics shares in Q4 2016, an estimated $656K.
  • Seres Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2741 holding.
  • BlackRock Institutional Trust first reported a position in Seres Therapeutics in Q3 2015 and has held it in 6 quarters since.
  • BlackRock Institutional Trust's Seres Therapeutics position peaked at $8.1M in Q2 2016.
  • 89 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.